Article info

Original research
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy

Authors

  1. Correspondence to Patricia Spilman; patricia.spilman{at}immunitybio.com
View Full Text

Citation

Reimann H, Nguyen A, Sanborn JZ, et al
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy

Publication history

  • Accepted May 10, 2021
  • First published June 25, 2021.
Online issue publication 
February 24, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.